The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Across the recent three months, 5 analysts have shared their insights on Axogen (NASDAQ:AXGN), expressing a variety of opinions spanning from bullish to bearish. The following table summarizes their ...
Along with Dale, there was a strong amount of insider activity from other executives later on in December. But while it's not certain why there were other insider sales to close 2025, it's certain ...
Hosted on MSN
Axogen targets at least 18% revenue growth in 2026 as BLA milestone strengthens market position
Axogen expects full-year 2026 revenue growth to be at least 18% or total revenue of at least $265.7 million. The company anticipates 2026 gross margin in the range of 74% to 76%, consistent with 2025, ...
AxoGen, Inc. (NASDAQ:AXGN), a leader in peripheral nerve injury solutions with a market capitalization of $660 million, has been making significant strides in the medical technology sector. The ...
ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen announced today the presentation of data from a clinical registry study entitled, Analysis of Quantitative Endpoints from a Multicenter Retrospective Registry ...
Essex Woodlands has acquired a stake in AxoGen Inc, an Alachua, Florida-based provider of surgical solutions for peripheral nerve injuries. According to the terms of the investment, Essex Woodlands ...
An update from AxoGen ( (AXGN)) is now available. At its June 23, 2026 annual meeting, Axogen shareholders representing roughly 85% of outstanding stock voted on director elections, auditor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results